Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Access Biotechnology
AddedFeb 13, 2024
UpdatedJun 28, 2026
Access Biotechnology

Access Biotechnology

Access Biotechnology, a NY-based life science investment arm, funds transformative therapies across biopharma stages.

HQ
New York City, NY, US
Founded
1986
Overview
Compare
Employees
Website

Access Biotechnology, based in New York, is the life science investment arm of Access Industries. The company focuses on funding transformative therapies aimed at addressing conditions with high unmet medical needs. Their investments span both private and public biopharma companies, covering a wide range of therapeutic areas, modalities, and stages of development, from early discovery technologies to late-stage clinical programs.

Notable figures associated with Access Biotechnology include key leaders from Access Industries. The company has achieved significant milestones, such as backing startups that have rapidly advanced to clinical stages and facilitating acquisitions by major pharmaceutical companies like Novartis. Their impact is marked by the approval of groundbreaking drugs and fostering innovation in the biotech sector, ultimately contributing to advancements in human health.

Access Biotechnology - Similar Companies

Bioventure Partners logo

Bioventure Partners

Ventura BioMed Investors logo

Ventura BioMed Investors

ventura-biomed.com

TigerGene logo

TigerGene

Enavate Sciences logo

Enavate Sciences

Agile Sciences logo

Agile Sciences

agilesci.com

ABio-X logo

ABio-X

abio-x.com

Therapyx logo

Therapyx

therapyxinc.com

Reichstein Biotech logo

Reichstein Biotech

Brace Pharma logo

Brace Pharma

bracepharma.com

Commerce Health Ventures logo

Commerce Health Ventures

Curie.Bio logo

Curie.Bio

curie.bio

Actio Biosciences logo

Actio Biosciences

actiobio.com

Empire Biotechnologies logo

Empire Biotechnologies

Acidophil logo

Acidophil

acidophil.com

Appia Bio logo

Appia Bio

appiabio.com

Access Biotechnology - Quick Facts

Who are Access Biotechnology's competitors?

Companies similar to Access Biotechnology include Bioventure Partners, Ventura BioMed Investors, TigerGene and Enavate Sciences.

When was Access Biotechnology founded?

Access Biotechnology was founded in 1986.

Where is Access Biotechnology's headquarters located?

Access Biotechnology's headquarters is located in New York City, NY, US.

How many employees does Access Biotechnology have?

Access Biotechnology has 8 employees as of Feb 4, 2024.

Access Biotechnology - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
Main Product
  • Biotech Investing
Tags
  • Biotech
  • Financial
  • Investing
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research